<DOC>
	<DOCNO>NCT00645112</DOCNO>
	<brief_summary>To compare safety efficacy cefdinir oral suspension , 7 mg/kg every 12 hour 5 day , azithromycin oral suspension 10 mg/kg/day ( Day 1 ) 5 mg/kg/day ( Days 2-5 ) total 5 day , child 6 month 6 year age , AOM .</brief_summary>
	<brief_title>A Comparison Safety Efficacy Cefdinir Oral Suspension Versus Azithromycin Pediatric Subjects With Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Cefdinir</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Clinical diagnosis , document medical history physical examination , AOM I 1 week . Clinical symptom include &gt; =1 following : Otalgia ( earache pain ) , may express ear pull nab ; Ear fullness ; Decreased hearing , may base report parent legally authorized representative ; Discharge external auditory canal ( follow acute perforation tympanic membrane ) . At least two ( 2 ) follow sign present least one ear : Full bulging perforate tympanic membrane , may erythematous ( note since hyperemia may present febrile cry child , red tympanic membrane alone insufficient diagnosis AOM ) ; Loss tympanic membrane landmark ( opacity tympanic membrane ) ; Abnormal tympanic membrane mobility biphasic pneumatic otoscopy , due presence pu fluid behind tympanic membrane edema tympanic membrane . Have evidence middle ear fluid demonstrate acoustic reflect tympanometry ( ear check ) show value 3 , 4 5 . Generally good health base medical history , vital sign , physical exam , historical laboratory result . Subject must suitable candidate oral antibiotic therapy . Previous enrollment study . Enrollment investigational study use unapproved product unapproved dos ; previous four week prior study start . Hypersensitivity reaction cefdinir , cephalosporin , azithromycin , macrolide azalide antibiotic , and/or sensitivity multiple allergen . Presence tympanostorny tube otitis externa Evaluation 1 . Systemic treatment antiinfective agent within 14 day prior Evaluation 1 study . Treatment longacting injectable antimicrobial agent ( e.g. , penicillin G benzathine ) within 4 week prior study drug administration . Concomitant infection require additional antimicrobial therapy . Evidence chronic , suppurative otitis medium . Evidence perforation tympanic membrane &gt; 24 hour . Evidence physiologic , anatomic , immunologic defect , would interfere resolution episode acute otitis medium . Immunocompromised subject ( e.g. , neutropenic subject ) . Presence disease , complicate factor ( e.g. , mastoiditis ) , structural abnormality would preclude evaluation subject 's therapeutic response . Any expectation treatment probenecid expect study drug administration period . Known significant renal hepatic impairment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>